Cardiovascular
Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAmong patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to s

Novel PCSK9 inhibitor cut LDL cholesterol levels by more than half

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainAmong patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to s
ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

by Elana GotkineFor patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6

ACC: Empagliflozin cuts heart failure hospitalization risk after AMI

by Elana GotkineFor patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6
German study confirms positive effect of anesthetic midazolam after cardiac arrest

German study confirms positive effect of anesthetic midazolam after cardiac arrest

byRuhr-Universitaet-BochumCredit: CC0 Public DomainIf a patient is successfully resuscitated after a cardiac arrest and circulation resumes, they are not out of the woods yet. A number of factor

German study confirms positive effect of anesthetic midazolam after cardiac arrest

byRuhr-Universitaet-BochumCredit: CC0 Public DomainIf a patient is successfully resuscitated after a cardiac arrest and circulation resumes, they are not out of the woods yet. A number of factor
Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

by Stephanie Lopez,Duke UniversityCredit: Pixabay/CC0 Public DomainAbout 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. T

Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure

by Stephanie Lopez,Duke UniversityCredit: Pixabay/CC0 Public DomainAbout 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. T
Ninerafaxstat well-tolerated and safe for nonobstructive hypertrophic cardiomyopathy

Ninerafaxstat well-tolerated and safe for nonobstructive hypertrophic cardiomyopathy

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainThe investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symp

Ninerafaxstat well-tolerated and safe for nonobstructive hypertrophic cardiomyopathy

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainThe investigational drug ninerafaxstat showed a good tolerability and safety profile, along with evidence of improvements in symp
Antihypertensive meds initiation linked to fractures in nursing home seniors

Antihypertensive meds initiation linked to fractures in nursing home seniors

by Elana GotkineFor longer-term nursing home residents, initiation of antihypertensive medication is associated with an increased risk for fractures and falls, according to a studypublished&nbsp

Antihypertensive meds initiation linked to fractures in nursing home seniors

by Elana GotkineFor longer-term nursing home residents, initiation of antihypertensive medication is associated with an increased risk for fractures and falls, according to a studypublished&nbsp
Chelation therapy does not improve outcomes after heart attack

Chelation therapy does not improve outcomes after heart attack

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainPeople with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy

Chelation therapy does not improve outcomes after heart attack

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainPeople with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy
Cardiology team performs novel heart artery repair with newly approved device

Cardiology team performs novel heart artery repair with newly approved device

by Liam Connolly,UC DavisCredit: UC DavisUC Davis Health cardiology team members are among the first in the country to treat patients with tricuspid regurgitation, or a leaky heart valve, by usi

Cardiology team performs novel heart artery repair with newly approved device

by Liam Connolly,UC DavisCredit: UC DavisUC Davis Health cardiology team members are among the first in the country to treat patients with tricuspid regurgitation, or a leaky heart valve, by usi
Salt substitution may reduce all-cause, cardiovascular mortality

Salt substitution may reduce all-cause, cardiovascular mortality

by Elana GotkineSalt substitution may reduce all-cause or cardiovascular mortality, according to a reviewpublishedonline April 9 in theAnnals of Internal Medicine.Hannah Greenwood, f

Salt substitution may reduce all-cause, cardiovascular mortality

by Elana GotkineSalt substitution may reduce all-cause or cardiovascular mortality, according to a reviewpublishedonline April 9 in theAnnals of Internal Medicine.Hannah Greenwood, f
Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trial

Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trial

byEuropean Society of CardiologyCredit: CC0 Public DomainThe first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic to

Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trial

byEuropean Society of CardiologyCredit: CC0 Public DomainThe first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic to